Compare Alcon AG (ALC) vs Box Inc (BOX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Box Inc — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while Box Inc trades at $28.94 (market cap $4.00B). The key difference: Alcon AG is far larger — about 8.2× Box Inc's market cap, and Alcon AG pays a 0.54% dividend while Box Inc pays none. Which is the better fit depends on your goals.
| ALC | BOX | |
|---|---|---|
Market Cap | $32.69B | $4.00B |
Sector | Health | Technology |
52-Week High | $92.22 | $33.73 |
52-Week Low | $62.02 | $21.37 |
Enterprise Value | $36.28B | $4.55B |
Dividend Yield | 0.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
BOX trades at $28.85, up 3.44% today, with a bullish technical signal from moving averages and strong analyst consensus. Revenue grew to $1.09B in 2025, with net income surging to $244.62M, though Q2 2026 EPS is expected at $0.4. The company expanded Box Zones to new regions, enhancing global data governance capabilities.
The outlook is positive with a $37 consensus price target, but risks include high P/E of 44.3 and overbought RSI levels. Earnings growth and strategic expansions present opportunities, yet investor caution is warranted near-term due to valuation and potential volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Box Inc
Box is a cloud-based content services platform that provides cloud-based storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file sync and sharing provider. More recently, however, the company has focused on bolstering its product portfolio by adding tools such as governance and e-signature that enhance workflow management and collaboration.
Read more on BOX →
